Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 251

The DOI matches its Crossref record.

Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis

Open access
Migliori, Giovanni Battista, Sotgiu, Giovanni, Gandhi, Neel R., Falzon, Dennis, DeRiemer, Kathryn, Centis, Rosella, Hollm-Delgado, Maria-Graciela, Palmero, Domingo, Pérez-Guzmán, Carlos, Vargas, Mario H., D'Ambrosio, Lia, Spanevello, Antonio, Bauer, Melissa, Chan, Edward D., Schaaf, H. Simon, Keshavjee, Salmaan, Holtz, Timothy H., Menzies, Dick, The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB · 2013 · European Respiratory Journal

Abstract

The broadest pattern of tuberculosis (TB) drug resistance for which a consensus definition exists is extensively drug-resistant (XDR)-TB. It is not known if additional drug resistance portends worsened patient outcomes. This study compares treatment outcomes of XDR-TB patients with and without additional resistance in order to explore the need for a new definition. Individual patient data on XDR-TB outcomes were included in a meta-analysis comparing outcomes between XDR alone and three nonmutually exclusive XDR-TB patient groups: XDR plus resistance to all the second-line injectables (sli) and capreomycin and kanamycin/amikacin (XDR+2sli) XDR plus resistance to second-line injectables and to more than one group 4 drug, i.e. ethionamide/protionamide, cycloserine/terizidone or para-aminosalicylic acid (XDR+sliG4) and XDR+sliG4 plus resistance to ethambutol and/or pyrazinamide (XDR+sliG4EZ). Of 405 XDR-TB cases, 301 were XDR alone, 68 XDR+2sli, 48 XDR+sliG4 and 42 XDR+sliG4EZ. In multivariate analysis, the odds of cure were significantly lower in XDR+2sli (adjusted OR 0.4, 95% CI 0.2–0.8) compared to XDR alone, while odds of failure and death were higher in all XDR patients with additional resistance (adjusted OR 2.6–2.8). Patients with additional resistance beyond XDR-TB showed poorer outcomes. Limitations in availability, accuracy and reproducibility of current drug susceptibility testing methods preclude the adoption of a useful definition beyond the one currently used for XDR-TB.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1183/09031936.00136312

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 251

Metadata

Authors
Migliori, G. B., Sotgiu, G., Gandhi, N. R., Falzon, D., DeRiemer, K., Centis, R., Hollm-Delgado, M.-G., Palmero, D., Pérez-Guzmán, C., Vargas, M. H., D'Ambrosio, L., Spanevello, A., Bauer, M., Chan, E. D., Schaaf, H. S., Keshavjee, S., Holtz, T. H., Menzies, D., & The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB
Venue
European Respiratory Journal
Published
2012-10-11
Volume
42
Issue
1
Pages
169-179
ISSN
  • 0903-1936 (ISSN-L)
  • 1399-3003
OpenAlex
W2147304416
Cited by
251
References
0
FWCI
4.03
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. https://app.cochat.ai/papers/10.1183/09031936.00136312
The paper
Migliori, G. B., Sotgiu, G., Gandhi, N. R., Falzon, D., DeRiemer, K., Centis, R., Hollm-Delgado, M.-G., Palmero, D., Pérez-Guzmán, C., Vargas, M. H., D'Ambrosio, L., Spanevello, A., Bauer, M., Chan, E. D., Schaaf, H. S., Keshavjee, S., Holtz, T. H., Menzies, D., & The Collaborative Group for Meta-Analysis of Individual Patient Data in MDR-TB. (2013). Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. European Respiratory Journal. https://doi.org/10.1183/09031936.00136312

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.